Drug Eluting Stent Market

 According to the current analysis of Reports and Data, the global  Coronary Stents market  was valued at USD 5.63 Billion in 2018 and is expected to reach USD 8.74 Billion by year 2026, at a CAGR of 5.67 %. The study covers in-depth analysis of Coronary Stents and its extensive use in the cardiovascular diseases. Coronary Stents are metal stents that are coated with a pharmacologic agent (drug) that is known to suppress restenosis (the reblocking or closing up of an artery after angioplasty due to excess growth inside or at the edge of the stent). Coronary Stents are usually preferred over bare metal stents for most people. Coronary Stents are generally to keep the blockage from recurring compared to bare metal stents. One of the major objectives of Coronary Stents is to limit neointimal hyperplasia. The global Coronary Stents market is propelled by number of factors such as rise in the geriatric population, increasing prevalence of cardiovascular diseases, growing acceptance for mini